[Rituximab (RTX), for which CD20 molecule is the target, proved to be less efficient in CLL than in lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE